…………………………………………………………………………………………………………………………………
Our platform of operation is customer oriented and originates from the long time experience of Rontis founders in the Healthcare Industry
Our target is to provide the full range of services and production capabilities to our customers in order to become the partner of choice
New Product Identification
Scientific, legal and commercial evaluation and recommendation, technological feasibility, product differentiation
Regulatory Strategy and experienced team for MA granting
Non Infringing and IP strategy ensuring product’s early launch
API and Drug product evaluation and recommendations, Selection of API Polymorph, Formulation Patents
Product Development ensuring finest quality
A qualified and competent team of scientists able to deliver efficient services and quality products
Bioequivalence and Clinical Trials
Selection of CRO, Designing Protocol, IVIVC/IVIVR studies, BCS waiver, Reformulation Strategies
Pharmaceutical Services
Development of IR to SR dosage forms, QbD implementation, Lab-scale Oral Formulation Development, Formulation Development of NCE, Bioavailability Enhancement of API through Formulation, Technology Transfer
New Drug Delivery Systems Development
Alternative Pharmaceutical Dosage Forms, Generic plus products, New combination products, Solubility/Permeability Enhancement Technologies, Modified Release Oral Formulations
Business Development
- Out licensing with supply
- Contract Manufacturing Projects
- Strategic Collaboration Partnerships
